U.S. markets closed
  • S&P Futures

    3,928.50
    +6.00 (+0.15%)
     
  • Dow Futures

    31,999.00
    +83.00 (+0.26%)
     
  • Nasdaq Futures

    13,318.25
    +16.25 (+0.12%)
     
  • Russell 2000 Futures

    2,297.40
    +12.30 (+0.54%)
     
  • Crude Oil

    63.32
    +0.10 (+0.16%)
     
  • Gold

    1,794.50
    -3.40 (-0.19%)
     
  • Silver

    28.05
    +0.19 (+0.69%)
     
  • EUR/USD

    1.2173
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.3890
    +0.0270 (+1.98%)
     
  • Vix

    21.34
    -1.77 (-7.66%)
     
  • GBP/USD

    1.4146
    +0.0004 (+0.03%)
     
  • USD/JPY

    105.9690
    +0.0870 (+0.08%)
     
  • BTC-USD

    50,421.28
    +89.12 (+0.18%)
     
  • CMC Crypto 200

    1,006.40
    -8.51 (-0.84%)
     
  • FTSE 100

    6,658.97
    +33.03 (+0.50%)
     
  • Nikkei 225

    30,166.62
    +494.92 (+1.67%)
     

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 23, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

ALAMEDA, Calif., Feb. 2, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2020 after market close on Tuesday, February 23, 2021 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2020 financial results will be issued after market close that day.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)
Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (833) 350-1434 for domestic and international callers (conference id: 6875748), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2020-earnings-release-and-conference-call-for-february-23-2021-301218391.html

SOURCE Penumbra, Inc.